Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery.
about
Drugs for preventing postoperative nausea and vomiting.Treatment of established postoperative nausea and vomiting: a quantitative systematic reviewNeurokinin-1 receptor antagonists in preventing postoperative nausea and vomiting: a systematic review and meta-analysisSystematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room - implications for the treatment of PONV and related clinical trialsAnaesthesia.Neurogenic inflammation in the context of migraine.Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.Gastroparesis: current diagnostic challenges and management considerationsAnti-emetics in development.Evidence-based management of postoperative nausea and vomiting: a review.Treatment of gastroparesis: a multidisciplinary clinical review.Prevention of postoperative nausea and vomiting.Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy.Management of postoperative nausea and vomiting: focus on palonosetronEffect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron.Pharmacologic management of postoperative nausea and vomiting.Safety of neurokinin-1 receptor antagonists.WITHDRAWN: Drugs for preventing postoperative nausea and vomiting.The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.Comparison of cyclizine and ondansetron for the prevention of postoperative nausea and vomiting in laparoscopic day-case gynaecological surgery.Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
P2860
Q24245545-CD447393-B6C4-447D-81D3-452C2ECCA173Q24795920-30BCE816-6123-4B49-9AEF-8B1DA61037BFQ26997344-A96C9A8F-FD93-400E-8272-3DB418E3365EQ33266461-D3673711-3353-44B2-A745-831118D3DC2CQ33721079-4BB9EFB4-9AB0-4B7B-B1F9-0F5C247B046EQ34218309-E9E14C33-38D9-4987-B5C3-1A6F1C77E692Q34600063-DD65540D-464F-4FAA-A588-C640398FE645Q34602527-5B0DFD5A-6764-4726-959D-5B8D73A68A2DQ34660860-07A8CA3A-9CB1-47AD-A3F3-20117768B69AQ35738180-323BFD97-C890-4CE5-A178-C2AD787071F3Q36428532-B7E50AAF-6318-4766-AB8A-E006D2F42681Q36698017-F0D90546-4467-42A1-B5DC-4F644F3E85D3Q36938306-F6796EAA-EA49-4543-9505-F3DFA401D5C5Q37230293-7707A7E1-EC59-41AF-A512-A4BE937401F5Q37305262-2C60B29A-E6B4-424F-AAE7-0A44B19E98EDQ37901057-B2B9373E-9FCE-4CD3-A61F-91F880FB3D42Q38109245-4BDDE9D4-3A7F-4BEB-ABF9-AEA6DEA981EAQ38675524-2B5618F2-1153-42E1-B34F-CEEACE90CBAAQ38977208-ABE530E4-C10D-497B-9C88-3F7DDFDC63DCQ43885566-B3D3DEF1-8A2C-4763-917E-C207D74C170CQ46254013-215C99DD-95B2-4BC6-9614-9CD7AA9310F6Q57161235-FDB0B1F2-7359-4A39-92FF-8A841ECC60EB
P2860
Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@en
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@nl
type
label
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@en
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@nl
prefLabel
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@en
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@nl
P2093
P356
P1476
Antiemetic activity of the NK1 ...... major gynaecological surgery.
@en
P2093
B A McQuade
B Bryssine
C F Spraggs
L E Cheli-Muller
P Diemunsch
P Schoeffler
P304
P356
10.1093/BJA/82.2.274
P407
P577
1999-02-01T00:00:00Z